N.J. Admin. Code § 13:39-3A.1

Current through Register Vol. 56, No. 21, November 4, 2024
Section 13:39-3A.1 - Continuing education credit hour requirements
(a) Each applicant for biennial license renewal shall complete a minimum of 30 credits of continuing education during the preceding biennial period, except that the Board shall not require completion of continuing education credits for an applicant's initial license renewal. At least 10 of the continuing education credits shall be obtained through didactic instruction. For purposes of this subsection, "didactic instruction" means in-person instruction and may include telephonic or electronic instruction that is interactive, but shall not include videotaped instruction. At least three continuing education credits shall be obtained in pharmacy law applicable to the practice of pharmacy in New Jersey. Commencing with the biennial renewal period beginning on May 1, 2017, at least one of the 30 continuing education credits shall, pursuant to P.L. 2017, c. 28, be in educational programs or topics concerning prescription opioid drugs, including alternatives to opioids for managing and treating pain, and the risks and signs of opioid abuse, addiction, and diversion. This one credit shall not be eligible for carry-over as described in (b) below.
1. In accordance with P.L. 2017, c. 28, if the Board deems it appropriate, on an individual basis, the Board may waive the specific one credit continuing education requirement concerning prescription opioid drugs. Any such waiver request shall be filed pursuant to N.J.A.C. 13:39-3A.5.
(b) Ten credits of continuing education may be carried over into a succeeding biennial period only if such credits were earned during the last six months of the preceding biennial period and were not previously reported.
(c) Each applicant for biennial license renewal who is authorized to administer vaccines and related emergency medications and who seeks renewal of Board approval granted pursuant to N.J.A.C. 13:39-4.21 shall complete the continuing education requirements set forth in that section. The Board shall consider these hours of continuing education towards the total number of credits required in (a) above.
(d) Each applicant for biennial license renewal who is granted authorization to engage in collaborative drug therapy management shall complete the continuing education requirements set forth in N.J.A.C. 13:39-13.3. The Board shall consider these hours of continuing education towards the total number of credits required in (a) above.

N.J. Admin. Code § 13:39-3A.1

Amended by 49 N.J.R. 3761(a), effective 12/4/2017